Mannie M D, Morrison-Plummer J, McConnell T J
Department of Microbiology and Immunology, East Carolina University School of Medicine, Greenville, NC 27858-4354.
J Immunol. 1993 Dec 15;151(12):7293-306.
The anti-CD4 mAb W3/25 inhibits experimental autoimmune encephalomyelitis (EAE) in Lewis rats by blocking Th cell responses to encephalitogenic determinants of myelin basic protein (MBP). However, it has yet to be resolved how W3/25 modulates CD4 to inhibit EAE-associated T cell responses. This study revealed that W3/25 profoundly inhibited MBP-stimulated proliferation by sensitized lymph node cells but only partially inhibited the respective response of uncloned and cloned lines of MBP-specific T cells. That is, low concentrations of W3/25 blocked 30 to 60% of MBP-stimulated proliferation, but 100-fold higher concentrations did not result in additional inhibition. W3/25 also inhibited MBP-induced acquisition of EAE transfer activity, but only in cultures of freshly isolated lymph node cells and not in cultures of continuously propagated T cells. Studies focusing on the GP2.E5 T cell line revealed that the lack of sensitivity to W3/25 in encephalitogenic and proliferative assays was nevertheless associated with an effective blockage of MBP-stimulated IL-2 production. Importantly, W3/25 specifically inhibited antigenic but not mitogenic stimulation of IL-2 production. Reverse transcriptase/polymerase chain reaction analyses revealed that MBP-activated GP2.E5 T cells produced mRNA for both IL-2 and IL-4, and that W3/25 selectively inhibited accumulation of IL-2 as compared to IL-4 mRNA. Thus, GP2.E5 T cells apparently express a IL-4-dependent pathway that confers resistance to the inhibitory activity of W3/25. Studies focusing on two CD4+ T cell hybridomas revealed that W3/25 profoundly inhibited MBP-stimulated IL-2 production but did not affect the alternative response of MBP-induced growth inhibition. Several other hybrids also mediated MBP-stimulated IL-2 production but did not express CD4 and were not affected by W3/25. These results indicate that: 1) interactions of W3/25 with CD4 do not necessarily block class II MHC-restricted recognition of MBP; and 2) expression of CD4 is not necessary for Ag recognition by several clonotypes of MBP-reactive T cells. Rather, the results of this study are consistent with the concept that W3/25 inhibits transduction of costimulatory signals that are required specifically for initiation of IL-2 production. These findings may have important implications for understanding the therapeutic potential of anti-CD4 mAb in autoimmune disease.
抗CD4单克隆抗体W3/25通过阻断Th细胞对髓鞘碱性蛋白(MBP)致脑炎决定簇的反应,抑制Lewis大鼠实验性自身免疫性脑脊髓炎(EAE)。然而,W3/25如何调节CD4以抑制与EAE相关的T细胞反应仍有待解决。本研究表明,W3/25可显著抑制致敏淋巴结细胞对MBP刺激的增殖,但仅部分抑制未克隆和克隆的MBP特异性T细胞系的相应反应。也就是说,低浓度的W3/25可阻断30%至60%的MBP刺激的增殖,但高100倍的浓度并不会导致额外的抑制。W3/25还可抑制MBP诱导的EAE转移活性的获得,但仅在新鲜分离的淋巴结细胞培养物中有效,而在连续传代的T细胞培养物中无效。对GP2.E5 T细胞系的研究表明,在致脑炎和增殖试验中对W3/25缺乏敏感性,但仍与MBP刺激的IL-2产生的有效阻断有关。重要的是,W3/25特异性抑制IL-2产生的抗原性刺激而非有丝分裂原性刺激。逆转录酶/聚合酶链反应分析显示,MBP激活的GP2.E5 T细胞产生IL-2和IL-4的mRNA,与IL-4 mRNA相比,W3/25选择性抑制IL-2的积累。因此,GP2.E5 T细胞显然表达了一种依赖IL-4的途径,使其对W3/25的抑制活性具有抗性。对两种CD4 + T细胞杂交瘤的研究表明,W3/25可显著抑制MBP刺激的IL-2产生,但不影响MBP诱导的生长抑制的替代反应。其他几种杂交瘤也介导MBP刺激的IL-2产生,但不表达CD4,也不受W3/25影响。这些结果表明:1)W3/25与CD4的相互作用不一定会阻断II类MHC限制的MBP识别;2)几种MBP反应性T细胞克隆型识别抗原并不需要CD4的表达。相反,本研究结果与W3/25抑制IL-2产生起始所需的共刺激信号转导的概念一致。这些发现可能对理解抗CD4单克隆抗体在自身免疫性疾病中的治疗潜力具有重要意义。